Compounding sterile preparations / E. Clyde Buchanan, RPh, MS, FASHP, Senior Director of Pharmacy (Ret.), Philip J. Schneider, MS, FASHP, FFIP, FASPEN, Professor and Associate Dean for Academic & Professional Affairs, University of Arizona College of Pharmacy, Phoenix Biomedical Campus, Phoenix, Atizona, Ryan A. Forrey, PharmD, FASHP, Senior Manager, Market Development for Hazardous Drug Safety, Becton, Dickinson and Company, Franklin Lakes, New Jersey
| Medienart: |
Buch |
|---|
| Erscheinungsjahr: |
[2018] © 2018 |
|---|---|
| Erschienen: |
Bethesda, MD: American Society of Health-System Pharmacists ; 2018 © 2018 |
| Ausgabe: |
4th edition |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Buchanan, E. Clyde [HerausgeberIn] |
|---|
| ISBN: |
|---|
| Nlm: |
QV 778 |
|---|---|
| BKL: | |
| Themen: |
Drug Compounding |
| Anmerkungen: |
Literaturangaben |
|---|
| Umfang: |
xvii, 574 Seiten ; Illustrationen, Diagramme ; 28 cm |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
877078181 |
|---|
| LEADER | 01000cam a2200265 4500 | ||
|---|---|---|---|
| 001 | 877078181 | ||
| 003 | DE-627 | ||
| 005 | 20230905071435.0 | ||
| 007 | tu | ||
| 008 | 170117s2018 xxu||||| 00| ||eng c | ||
| 010 | |a 2017001193 | ||
| 020 | |a 9781585284849 |c : pbk. |9 978-1-58528-484-9 | ||
| 020 | |a 158528484X |c : pbk. |9 1-58528-484-X | ||
| 035 | |a (DE-627)877078181 | ||
| 035 | |a (DE-599)GBV877078181 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 044 | |c XD-US | ||
| 050 | 0 | |a RS199.S73 | |
| 060 | 0 | |a QV 778 | |
| 082 | 0 | |a 615/.19 |q LOC |2 23 | |
| 084 | |a 58.28 |2 bkl | ||
| 245 | 1 | 0 | |a Compounding sterile preparations |c E. Clyde Buchanan, RPh, MS, FASHP, Senior Director of Pharmacy (Ret.), Philip J. Schneider, MS, FASHP, FFIP, FASPEN, Professor and Associate Dean for Academic & Professional Affairs, University of Arizona College of Pharmacy, Phoenix Biomedical Campus, Phoenix, Atizona, Ryan A. Forrey, PharmD, FASHP, Senior Manager, Market Development for Hazardous Drug Safety, Becton, Dickinson and Company, Franklin Lakes, New Jersey |
| 250 | |a 4th edition | ||
| 264 | 1 | |a Bethesda, MD |b American Society of Health-System Pharmacists |c [2018] | |
| 264 | 4 | |c © 2018 | |
| 300 | |a xvii, 574 Seiten |b Illustrationen, Diagramme |c 28 cm | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Literaturangaben | ||
| 650 | 0 | |a Sterilization | |
| 650 | 0 | |a Pharmaceutical technology | |
| 650 | 0 | |a Drugs |x Dosage forms | |
| 650 | 2 | |a Technology, Pharmaceutical |x standards | |
| 650 | 2 | |a Drug Compounding |x standards | |
| 650 | 2 | |a Sterilization |x standards | |
| 650 | 2 | |a Drug Contamination |x prevention & control | |
| 689 | 0 | 0 | |D s |0 (DE-588)4045699-7 |0 (DE-627)104162406 |0 (DE-576)209066407 |a Pharmazeutische Technologie |2 gnd |
| 689 | 0 | 1 | |D s |0 (DE-588)4295343-1 |0 (DE-627)104175435 |0 (DE-576)210969113 |a Sterilität |g Hygiene |2 gnd |
| 689 | 0 | |5 (DE-627) | |
| 700 | 1 | |a Buchanan, E. Clyde |e herausgeberin |4 edt | |
| 700 | 1 | |a Schneider, Philip J. |e herausgeberin |4 edt | |
| 700 | 1 | |a Forrey, Ryan A. |e herausgeberin |4 edt | |
| 912 | |a GBV_ILN_20 | ||
| 912 | |a ISIL_DE-84 | ||
| 912 | |a SYSFLAG_1 | ||
| 912 | |a GBV_KXP | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a SSG-OPC-DE-84 | ||
| 936 | b | k | |a 58.28 |j Pharmazeutische Technologie |0 (DE-627)106417622 |
| 951 | |a BO | ||
| 953 | |2 045F |a 615/.19 | ||
| 980 | |2 20 |1 01 |x 0084 |b 1826403930 |c 00 |f LS2 |d PM C 427 |e --%%-- |j --%%-- |c 09 |f MAG |d 2956-0657 |e --%%-- |j --%%-- |y k |z 06-02-19 | ||
| 984 | |2 20 |1 01 |x 0084 |a 84$103462749 | ||